Bipolar disorder affects 40-50 million people globally, with genetic heritability between 60-80%, and can be triggered by both positive and negative life events, including promotions or new ...
Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...